Published by
@ShahidNShah
@ShahidNShah
0-50Healthcare
780 East Main St., Suite 1, Branford, Connecticut, 06405, United States
Women’s health conditions have not received the attention they deserve. At DotLab™, we’re changing that. We’re on a mission to advance women’s healthcare into an era of precision medicine by developing breakthrough, actionable technologies that lead to better health outcomes for women.
Initially, the company is harnessing its expertise with novel, cutting-edge biomarkers and the power of machine learning to deliver the first non-invasive tool to diagnose endometriosis, resulting in a paradigm shift in the identification and management of the disease. DotLab will also pioneer data-driven management of women’s health diseases through the collection of real-world, longitudinal data across multiple timepoints.
DotEndo™ is a first-of-its-kind blood test that aids in the diagnosis of active endometriosis. DotEndo is a non-invasive test that applies an algorithm to the differential expression levels of …
Posted Clinical Diagnostics & Research Tools Infertility Diagnosis
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 15, 2024 at 12:42pm